Abstract:Abstract Background Spontaneous regression of malignant tumors is a rare phenomenon, especially in primary lung cancer. The underlying mechanisms remain unclear, but they may often involve immunological mechanisms. Case presentation In January 2020, a 78-year-old female underwent examination during follow-up of interstitial pneumonia. Chest X-ray and computed tomography (CT) scan revealed a 1.2 × 1.2 cm nodule in the left lower lobe. Based on CT-guided percutaneous transthoracic needle biopsy (PTNB), it was diagnosed as small cell lung cancer (SCLC). Immunohistochemical staining showed that tumor cells were positive for CD56, synaptophysin, and chromogranin A. Twenty-three days after the CT-guided PTNB, repeat CT scan showed that the tumor size regressed to 0.6 × 0.6 cm. The tumor showed positive uptake in fluorodeoxyglucose (FDG) positron emission tomography (PET)–CT. The maximum standardized uptake value of the nodule was 2.24. PET–CT and enhanced magnetic resonance imaging of the brain showed no distant or lymph node metastasis. The patient’s preoperative disease was diagnosed as cT1aN0M0, stageIA1, SCLC. In March 2020, she underwent left lower lobectomy and mediastinal lymph node dissection. Pathological examination of the resected specimen showed that the small tumor cells were dense with a high nucleus to cytoplasm ratio, and the morphological diagnosis was small cell carcinoma. The resected tumor size regressed to 0.05 × 0.02 cm, and no lymph node metastasis was observed. Because it was extremely small, immunohistochemical staining could not be conducted. Active fibrosis and inflammation were present around the tumor. Finally, the patient was pathologically diagnosed as SCLC pT1miN0M0, stage IA1. The patient is alive without recurrence 23 months after surgery with no adjuvant therapy. Conclusions We present a rare surgical case of pathologically confirmed spontaneous regression of SCLC after CT-guided PTNB. Although spontaneous regression is extremely rare, we should recognize this phenomenon.

Spontaneous regression of recurrent pulmonary large cell neuroendocrine carcinoma with alteration of PD‐L1 expression after surgical resection: A case report

Submucosal Small-Cell Neuroendocrine Carcinoma of the Larynx Detected Using 18F-Fluorodeoxyglucose Positron Emission Tomography/computed Tomography: A Case Report and Review of the Literature

Neoadjuvant immunochemotherapy for pulmonary large-cell neuroendocrine carcinoma: case report

Complete remission of combined pulmonary large cell neuroendocrine carcinoma: a case report

Pathologically confirmed spontaneous regression of small cell lung cancer after computed tomography-guided percutaneous transthoracic needle biopsy followed by surgery

Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma: a SEER population-based study

Large Cell Neuroendocrine Carcinoma Of The Lungs: Case Report And Literature Review

Clinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung

Pulmonary large cell neuroendocrine carcinoma (LCNEC): a population-based study addressing recent molecular-genetic advances and emerging therapeutic approaches

Perioperative serplulimab‐based chemoimmunotherapy in stage IV large cell neuroendocrine carcinoma of the lung: A case report

A very rare case of spontaneous regression of basaloid squamous cell carcinoma of the lung

Clinical Features And Outcomes Analysis Of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy

Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection

Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience

Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial Carcinoma

Genomic Feature of a Rare Case of Mix Small-Cell and Large-Cell Neuroendocrine Lung Carcinoma: A Case Report

Combined large‑cell neuroendocrine carcinoma and small‑cell lung cancer: A case report

Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma

Outcomes of Patients with Clinical Stage I-IIIA Large-Cell Neuroendocrine Lung Cancer Treated with Resection

Large Cell Neuroendocrine Tumor Size >3 cm Negatively Impacts Long-Term Outcomes After R0 Resection

Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas